Fundz
You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →

UCLA Health Jonsson Comprehensive Cancer Center receives $3.9M grant from NCI to develop cancer immunotherapy strategies for melanoma treatment.

PRIVATESep 18, 2026about 3 hours ago

Amount Raised

$3.9 Million

Round Type

Seed

Los AngelesBiotechnologyHealth CareMedical

Investors

National Cancer Institute (Nci)

Description

Cristina Puig-Saus and her research team at UCLA Health Jonsson Comprehensive Cancer Center have received a five-year, $3.9 million grant from the National Cancer Institute (NCI). The funding will support the development of drug-based strategies to enhance cancer immunotherapy for patients with melanoma and potentially other cancer types. The grant reflects NCI's commitment to advancing innovative cancer treatment approaches.

Company Information

Company

UCLA Health Jonsson Comprehensive Cancer Center

Location

Los Angeles, California, United States

About

Cristina Puig-Saus and her research team at UCLA are developing drug-based strategies to enhance cancer immunotherapy for melanoma and other cancer types. The team includes faculty from the David Geffen School of Medicine at UCLA and researchers from the UCLA Health Jonsson Comprehensive Cancer Center, focusing on innovative approaches to improve patient outcomes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment UCLA Health Jonsson Comprehensive Cancer Center raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015
Predictive Intelligence
Strategic

ML-powered predictions for UCLA Health Jonsson Comprehensive Cancer Center's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

UCLA Health Jonsson Comprehensive Cancer Center raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.